• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cambia Health, Mosiac Health Partner to Launch Echo Health Ventures

by Jasmine Pennic 11/16/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

echo-health-ventures

Cambia Health Solutions and Mosiac Health Solutions have teamed up to launch Echo Health Ventures, a partnership that combines the proven digital health investment expertise of both organizations to scale funding in existing innovative solutions. Together, Echo Ventures will work to build successful new digital health companies to deliver value that is responsive to systems, providers and consumers.

The healthcare system is facing a crisis – nearly 20% of Americans lack access to basic care and less than half of consumers are satisfied with their healthcare experience. And despite new health startups cropping up every day with the promise of changing our system, half fail within two years of launch.

To help provide healthcare transformation, Echo Health Ventures builds on the success of Mosaic and Cambia’s strategic investment division to demonstrate an unmatched value proposition for stakeholders across the entire health care ecosystem, including:

·  Unmatched investment sourcing and industry relationships across the US

·  Access to deep industry knowledge and resources from two leading health solutions companies with demonstrated experience in providing products and services to millions of Americans

·  National scale and access to human capital, supporting a greater speed-to-market for critical innovations in the health care industry

·  Long-term commitment and stage-agnostic approach to investing focused on consumer needs and health care of the future

·   Specialized support for entrepreneurs and innovative companies as they develop the next paradigm for our health care system

·   Active cultivation of strategic distribution partnerships among portfolio companies when appropriate

Former Cambia President, Rob Coppedge has been appointed CEO of Echo Health Ventures by the governing boards and brings over 20 years of health care venture funding experience.

Echo Health Ventures operates nationwide with offices in Durham, N.C., Portland, Ore. and Seattle. Echo Health current portfolio includes AxisPoint Health, Caremerge, Maxwell Health, Pokitdok and Tytocare.

“The next great health care companies will personalize health care, reduce costs and focus on the consumer – not the enterprise,” said Rob Coppedge. “By leveraging the strength of Cambia and Mosaic, we are able to bring significant value to our portfolio companies. Whether they are early stage startups or well established growth companies, Echo will uniquely support getting their innovations to scale faster and more successfully across the multi-trillion dollar health care market.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Cambia Health Solutions, Echo Health Ventures, Mosaic Health Solutions, Mosaic Ventures

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |